Efficacy and Safety of a Novel k-Agonist for Managing Intractable Pruritus in Dialysis Patients
American Journal of Nephrology, 08/03/2012
Clinical Article
Kumagai H et al. – Nalfurafine hydrochloride, orally administered at 5 μg/day for 52 weeks to hemodialysis patients, produced a long–term suppression of pruritus without significant safety problems.



